AEMD - Company ID 0000882291
The table below shows AETHLON MEDICAL INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$7.65M | -$10.13M | -$10.51M | -$9.77M | -$6.76M | -$5.20M |
| Capital expenditure | $0.00 | $250.87K | $943.11K | $349.19K | $59.88K | $151.66K |
| Investing cash flow | $0.00 | -$250.87K | -$943.11K | -$349.19K | -$59.88K | -$151.66K |
| Dividends paid | - | - | - | - |
AETHLON MEDICAL INC reported operating cash flow of -$7.65M for fiscal year 2025. That is up 24.5% from -$10.13M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$4.33M (FY 2016) to -$7.65M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $7.73M | $1.29M | $8.91M | $17.37M | $7.13M | $11.13M |